MTOR and breast carcinoma: The cultivation of breast cancer cells with AZD8055 caused the emergence of AZD8055-resistant clones that harbored increased mTOR kinase activity due to single amino acid mutations in the mTOR kinase domain that led to increased kinase activity [35].